| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 258.432 | 349.583 | 347.621 | 266.563 | 364.739 | 204.636 | 542.253 | 585.206 | 505.692 | 335.193 |
| Total Income - EUR | 415.456 | 474.762 | 402.081 | 298.054 | 509.924 | 360.451 | 539.124 | 612.936 | 723.268 | 529.490 |
| Total Expenses - EUR | 397.509 | 415.361 | 360.639 | 267.096 | 424.747 | 328.566 | 368.095 | 365.527 | 419.457 | 455.500 |
| Gross Profit/Loss - EUR | 17.947 | 59.401 | 41.442 | 30.957 | 85.177 | 31.885 | 171.029 | 247.409 | 303.811 | 73.990 |
| Net Profit/Loss - EUR | 14.408 | 49.949 | 35.479 | 28.144 | 83.157 | 24.991 | 168.110 | 240.280 | 299.475 | 73.990 |
| Employees | 5 | 7 | 4 | 4 | 3 | 1 | 1 | 2 | 4 | 2 |
Check the financial reports for the company - Farmacon Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 346.935 | 298.830 | 246.732 | 203.649 | 313.452 | 289.342 | 581.987 | 1.056.589 | 1.155.411 | 1.168.514 |
| Current Assets | 236.765 | 186.239 | 178.376 | 472.179 | 339.192 | 260.234 | 347.693 | 279.306 | 627.421 | 797.432 |
| Inventories | 179.132 | 151.613 | 109.419 | 304.025 | 248.050 | 163.521 | 241.140 | 251.932 | 549.149 | 784.868 |
| Receivables | 51.765 | 36.349 | 16.577 | 33.789 | 76.942 | 42.862 | 87.342 | 22.625 | 64.436 | 4.682 |
| Cash | 5.869 | -1.723 | 52.381 | 134.364 | 14.201 | 53.851 | 19.211 | 4.748 | 13.836 | 7.882 |
| Shareholders Funds | 135.904 | 162.706 | 195.432 | 219.989 | 298.886 | 318.211 | 483.487 | 725.267 | 1.022.542 | 1.090.818 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 447.796 | 322.362 | 222.511 | 414.459 | 353.758 | 231.365 | 446.193 | 610.628 | 760.290 | 875.129 |
| Income in Advance | 0 | 0 | 7.165 | 41.379 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Farmacon Srl